Modulating Tumor Microenvironment with pH-Responsive Nanomaterials for Cancer Immunotherapy

来源 :第三届国际纳米药物大会 ChinaNanomedicine 2018 The 3rd International Con | 被引量 : 0次 | 上传用户:shgrx
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  Cancer therapy by employing synthetic materials as delivery carriers has made great progress in recent decades.However,the therapeutic efficacy of nanocarriers has only been moderately improved due to the existence of tremendous delivery barriers exposed by the complicated physiological and tumor microenvironment.
其他文献
  In the past two decades,the stability of block copolymer micelles has been being one of the most concerning issues due to the presence of the critical micel
会议
  Inflammation serves as a natural defense mechanism to protect living organisms from infectious diseases.Nonsteroidal anti-inflammatory drugs(NSAIDs)can help
会议
  Protein therapeutics with highly specific activity and low toxicity the protein drugs,including antibodies,enzymes and cytokines,show significant promise fo
会议
  The Sub-5 nm ultrasmall were useful for cancer radiation therapy as well as bioimaging.1 The ultrasmall gold clusters radiosensitizer(Au10-12,Au25,and Au29-
会议
  Photodynamic therapy is the use of photosensitizers to convert molecular oxygen into toxic 1O2 under the light irradiation to kill cancer cells.
会议
  Traditional strategy for specific drug delivering is by constructing a responsive nanocarrier,which prove to effective in increasing drug efficiency and dec
会议
  Gadolinium-containing metallofullerenes have been suggested as MRI agents due to their paramagnetic properties and high relativity.Since 2004,we found that
会议
  A combination of tumor-activatable prodrug and tumor-targeted delivery could substantially enhanced the selectivity of selectivity of chemotherapy.A series
会议
  Tumor stromal cells(TSCs)and their secreted extracellular matrix(ECM)form major barriers for drug delivery and penetration into tumor tissue.To explore stro
会议
  The present work was carried out to explore the idea of subverting the GBM immunosuppressive microenvironment through DC-mediated delivery of doxorubicin-po
会议